Patents Assigned to SHENGKE PHARMACEUTICALS (JIANGSU) LTD.
  • Patent number: 11091485
    Abstract: Provided is an imidazo[1?,2?:1,6]pyrido[2,3-d]pyrimidine compound of general formula (I). The compound can be used in treating a cell proliferative disorder and is a cyclin-dependent kinase (CDK) inhibitor with broad-spectrum and strong activity.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: August 17, 2021
    Assignee: SHENGKE PHARMACEUTICALS (JIANGSU) LTD.
    Inventors: Bin Liu, Hang Cheng, Weiyan Xiong, Chenggang Zhang, Chengzhi Yu